Sfoglia per Relatore
In vivo evaluation of a chronic treatment with a 5-HT2 agonist on visual impairment in a mouse model of stroke: a pilot study
2021/2022 TIDEI, SARA
Novel strategies for glioblastoma: integrating repurposed drugs with differentiation treatment
2024/2025 MENEGAZZI, ELIO
ß-glucan triggers HSPCs mobilization by downregulating OSM in the bone marrow: a possible trained immunity strategy against sepsis in diabetes
2024/2025 ZORZI, GIULIA
| Tipologia | Anno | Titolo | Titolo inglese | Autore | File |
|---|---|---|---|---|---|
| Lauree magistrali | 2021 | In vivo evaluation of a chronic treatment with a 5-HT2 agonist on visual impairment in a mouse model of stroke: a pilot study | In vivo evaluation of a chronic treatment with a 5-HT2 agonist on visual impairment in a mouse model of stroke: a pilot study | TIDEI, SARA | |
| Lauree magistrali | 2024 | Novel strategies for glioblastoma: integrating repurposed drugs with differentiation treatment | Novel strategies for glioblastoma: integrating repurposed drugs with differentiation treatment | MENEGAZZI, ELIO | |
| Lauree magistrali | 2024 | ß-glucan triggers HSPCs mobilization by downregulating OSM in the bone marrow: a possible trained immunity strategy against sepsis in diabetes | ß-glucan triggers HSPCs mobilization by downregulating OSM in the bone marrow: a possible trained immunity strategy against sepsis in diabetes | ZORZI, GIULIA |
Legenda icone
- file ad accesso aperto
- file ad accesso riservato
- file sotto embargo
- nessun file disponibile